We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BVS market cap is 865.92M. The company's latest EPS is USD -1.9251 and P/E is -5.53.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 120.79M | 135.42M | 129.46M | 151.22M | 138.96M |
| Operating Income | -74.89M | 2.65M | 5.33M | -29.07M | 4.56M |
| Net Income | -7.3M | -6.1M | -4.57M | -23.99M | -14.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 340.14M | 321.16M | 430.9M | 512.12M | 512.35M |
| Operating Income | 31.19M | 21.24M | 17.74M | -251.05M | -77.43M |
| Net Income | 6.85M | 16.41M | 19.38M | -158.7M | -156.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 811.1M | 810.91M | 794.24M | 792.17M | 769.49M |
| Total Liabilities | 584.65M | 589.79M | 576.81M | 603.11M | 582.66M |
| Total Equity | 226.46M | 221.12M | 217.43M | 189.06M | 186.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 472.41M | 494.47M | 1.23B | 1.37B | 810.91M |
| Total Liabilities | 326.79M | 350.31M | 692.07M | 1.03B | 589.79M |
| Total Equity | 145.62M | 144.16M | 533.79M | 340.33M | 221.12M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.97M | 15.34M | -6.01M | 9.16M | 19.47M |
| Investing | 16.4M | 15.81M | -1M | -1.08M | -1.14M |
| Financing | -26.64M | -26.65M | -4.24M | -12.09M | -11.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 40.71M | 71.8M | 22.99M | -13.54M | 15.34M |
| Investing | -7.91M | -20.5M | -283.76M | -116.44M | 15.81M |
| Financing | -11.06M | -29.57M | 273.37M | 62.08M | -26.65M |
| Market Cap | 865.92M |
| Price to Earnings Ratio | -5.53 |
| Price to Sales Ratio | 1.69 |
| Price to Cash Ratio | 23.38 |
| Price to Book Ratio | 3.91 |
| Dividend Yield | - |
| Shares Outstanding | 81.15M |
| Average Volume (1 week) | 234.24k |
| Average Volume (1 Month) | 297.91k |
| 52 Week Change | 102.47% |
| 52 Week High | 14.38 |
| 52 Week Low | 3.90 |
| Spread (Intraday) | 4.69 (40.5%) |
| Company Name | Bioventus Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bioventus.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
